The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target.

Autor: Yamada, Yoshihiro, Pannell, Richard, Forster, Alan, Rabbitts, Terence H.
Předmět:
Zdroj: Oncogene; 2/21/2002, Vol. 21 Issue 9, p1309, 7p, 3 Color Photographs, 1 Diagram, 1 Chart
Abstrakt: Presents a study that evaluated a function of LMO2 in the angiogenesis of primary tumors and in tumors implanted in mice. Results; Discussion; Methodology.
Databáze: Complementary Index